Cargando…

3D Non-Local Neural Network: A Non-Invasive Biomarker for Immunotherapy Treatment Outcome Prediction. Case-Study: Metastatic Urothelial Carcinoma

Immunotherapy is regarded as one of the most significant breakthroughs in cancer treatment. Unfortunately, only a small percentage of patients respond properly to the treatment. Moreover, to date, there are no efficient bio-markers able to early discriminate the patients eligible for this treatment....

Descripción completa

Detalles Bibliográficos
Autores principales:	Rundo, Francesco, Banna, Giuseppe Luigi, Prezzavento, Luca, Trenta, Francesca, Conoci, Sabrina, Battiato, Sebastiano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8321180/ https://www.ncbi.nlm.nih.gov/pubmed/34460530 http://dx.doi.org/10.3390/jimaging6120133

Ejemplares similares

Deep Neuro-Vision Embedded Architecture for Safety Assessment in Perceptive Advanced Driver Assistance Systems: The Pedestrian Tracking System Use-Case
por: Rundo, Francesco, et al.
Publicado: (2021)

An Advanced Bio-Inspired PhotoPlethysmoGraphy (PPG) and ECG Pattern Recognition System for Medical Assessment
por: Rundo, Francesco, et al.
Publicado: (2018)

Editorial: Bio-Inspired Physiological Signal(s) and Medical Image(s) Neural Processing Systems Based on Deep Learning and Mathematical Modeling for Implementing Bio-Engineering Applications in Medical and Industrial Fields
por: Rundo, Francesco, et al.
Publicado: (2021)

Advanced eNose-Driven Pedestrian Tracking Pipeline for Intelligent Car Driver Assisting System: Preliminary Results
por: Rundo, Francesco, et al.
Publicado: (2022)

Non–Muscle Invasive Papillary Urothelial Carcinoma Metastatic to the Mandible
por: Frydenlund, Noah, et al.
Publicado: (2018)

A Benchmark Evaluation of Adaptive Image Compression for Multi Picture Object Stereoscopic Images
por: Ortis, Alessandro, et al.
Publicado: (2021)

The Promise of Digital Biopsy for the Prediction of Tumor Molecular Features and Clinical Outcomes Associated With Immunotherapy
por: Banna, Giuseppe Luigi, et al.
Publicado: (2019)

Navigating the Rapidly Evolving Advanced Urothelial Carcinoma Treatment Landscape: Insights from Italian Experts
por: Santini, Daniele, et al.
Publicado: (2023)

Role of immunotherapy in localized muscle invasive urothelial cancer
por: Kaur, Jasmeet, et al.
Publicado: (2021)

Significance of tumor-associated neutrophils, lymphocytes, and neutrophil-to-lymphocyte ratio in non-invasive and invasive bladder urothelial carcinoma
por: Hassan, Wael Abdo, et al.
Publicado: (2023)

Novel immunotherapy approaches for metastatic urothelial and renal cell carcinoma
por: Shao, Zhiying, et al.
Publicado: (2016)

Comparison Between Urothelial and Non-Urothelial Urethral Cancer
por: Wenzel, Mike, et al.
Publicado: (2021)

Current Status and Future Perspectives of Immunotherapy for Locally Advanced or Metastatic Urothelial Carcinoma: A Comprehensive Review
por: Kim, Tae Jin, et al.
Publicado: (2020)

The impact of eligibility for maintenance immunotherapy on prognosis in patients with unresectable or metastatic urothelial carcinoma
por: Ozaki, Kai, et al.
Publicado: (2021)

Prognostic role of systemic inflammation indexes in metastatic urothelial carcinoma treated with immunotherapy
por: Dionese, Michele, et al.
Publicado: (2023)

Tumor associated macrophages polarization dictates the efficacy of BCG instillation in non-muscle invasive urothelial bladder cancer
por: Suriano, Francesca, et al.
Publicado: (2013)

Metastatic Urothelial Carcinoma of the Prepuce and Glans Penis: Suspected Implantation of Non-Muscle-Invasive Bladder Cancer via Urine
por: Makino, Tomoyuki, et al.
Publicado: (2014)

Herpes zoster granulomatous dermatitis in metastatic lung cancer treated with nivolumab: A case report
por: Gozzi, Elisa, et al.
Publicado: (2020)

Alectinib in the treatment of ocular metastases of ALK rearranged non small cell lung cancer: Description of 2 case reports
por: Gozzi, Elisa, et al.
Publicado: (2020)

Erdafitinib for locally advanced or metastatic urothelial carcinoma
por: Siefker-Radtke, Arlene O, et al.
Publicado: (2022)

Development of a Prognostic AI-Monitor for Metastatic Urothelial Cancer Patients Receiving Immunotherapy
por: Trebeschi, Stefano, et al.
Publicado: (2021)

Homologous Recombination Related Signatures Predict Prognosis and Immunotherapy Response in Metastatic Urothelial Carcinoma
por: Li, Pan, et al.
Publicado: (2022)

A CASE OF RAPIDLY PROGRESSIVE RETINOPATHY ASSOCIATED WITH PEMBROLIZUMAB IMMUNOTHERAPY FOR METASTATIC UROTHELIAL CARCINOMA
por: Sakai, Daiki, et al.
Publicado: (2023)

Novel and emerging approaches in the management of non-muscle invasive urothelial carcinoma
por: Yassaie, Omid, et al.
Publicado: (2021)

Sex-related differences in non-urothelial variant histology, non-muscle invasive bladder cancer
por: Flammia, Rocco Simone, et al.
Publicado: (2022)

Metastatic urothelial carcinoma()()
por: Gómez-Moyano, Elisabeth, et al.
Publicado: (2021)

Case report: Metastatic urothelial cancer with an exceptional response to immunotherapy and comprehensive understanding of the tumor and the tumor microenvironment
por: Sternberg, Cora N., et al.
Publicado: (2022)

Neoadjuvant immunotherapy for muscle invasive urothelial bladder carcinoma: will it change current standards?
por: Renner, Alex, et al.
Publicado: (2021)

Cerebral metastasis during remission after immunotherapy for metastatic urothelial carcinoma: A case report
por: Iwata, Shohei, et al.
Publicado: (2021)

Complement and coagulation cascades pathway-related signature as a predictor of immunotherapy in metastatic urothelial cancer
por: Gong, Zheng, et al.
Publicado: (2023)

Editorial: Beyond chemotherapy and immunotherapy in thoracic malignancies: Overcoming resistance by tackling new molecular pathways
por: Mountzios, Giannis, et al.
Publicado: (2022)

Validation of grading of non-invasive urothelial carcinoma by digital pathology for routine diagnosis
por: Colling, Richard, et al.
Publicado: (2021)

Fighting Deepfakes by Detecting GAN DCT Anomalies
por: Giudice, Oliver, et al.
Publicado: (2021)

A phase II trial of durvalumab and tremelimumab in metastatic, non‐urothelial carcinoma of the urinary tract
por: Sarfaty, Michal, et al.
Publicado: (2020)

Clinical Outcomes of Patients With Metastatic Urothelial Carcinoma After Progression to Immune Checkpoint Inhibitors: A Retrospective Analysis by the Meet-Uro Group (Meet-URO 1 Study)
por: Bersanelli, Melissa, et al.
Publicado: (2021)

Immunotherapy for Metastatic Non-Small Cell Lung Cancer: Therapeutic Advances and Biomarkers
por: Russano, Marco, et al.
Publicado: (2023)

Identifying successful biomarkers for patients with non-small-cell lung cancer
por: Friedlaender, Alex, et al.
Publicado: (2019)

Meta-analysis of neoadjuvant immunotherapy for non-metastatic colorectal cancer
por: Zhou, Long, et al.
Publicado: (2023)

Immunotherapy beyond progression in patients with advanced non-small cell lung cancer
por: Ge, Xiangwei, et al.
Publicado: (2020)

Immunotherapy with or without targeted therapy for metastatic upper tract urothelial carcinoma: case report and literature review
por: Ni, Kangxin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8sain841p912tmjjqo0csaic0m